Skip to content

Fujifilm Feature Comparison Reader Study to Compare Old vs New Processing

A Feature Comparison Study to Evaluate the Modified Processing of Fujifilm's ASPIRE Cristalle With Digital Breast Tomosynthesis Option as Compared to the Original Processing

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03586583
Enrollment
600
Registered
2018-07-13
Start date
2018-06-30
Completion date
2018-11-19
Last updated
2023-09-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Brief summary

The purpose of the feature comparison study is to evaluate general mammographic features in images of the same breast when reconstructed with modified (ISR and DVIIm) processing as compared to the original processing (FBP with EDR and MFP).

Detailed description

This clinical research is a retrospective, feature comparison reader study with an enriched sample of 600 (100 per radiologist) breast screening or diagnostic cases which were selected from the library of mammograms collected under Fujifilm protocol FMSU2013-004A (all subjects previously provided written informed consent agreeing their image data and supporting documentation could be used for future research and investigations). Six MQSA-qualified and board-certified mammographers representing various experience levels, will be shown DBT images of a breast with the modified processing side-by-side the same breast with the original processing on the ASPIRE Bellus II workstation.. One breast per subject (two views per breast; CC and MLO) will be evaluated by the readers. Readers will be blinded to the image reconstruction and presentation processing methods. Each reader will be given a different sample of cases to review. Approximately 600 total cases (100 cases per reader) will compose the sample. The order of the subjects and location (left or right review workstation high resolution monitor) of the images with modified processing will be randomized for each reader. The primary objective is the readers' assessment for each of the 7 general mammographic features. The null hypothesis is that the pooled proportion of cases judged as non-inferior with modified image processing is \<0.50, versus the alternative hypothesis that the pooled proportion is \>0.50. If the 95% CI does not contain values \<0.50, then the null hypothesis will be rejected. These hypotheses will be evaluated for each of the 7 general mammographic features. If all 7 null hypotheses are rejected, then it will be concluded that the modified imaging features are non-inferior to the original imaging

Interventions

DEVICEFBP

Old processing

DEVICEISR

New processing

Sponsors

International HealthCare, LLC
CollaboratorOTHER
Fujifilm Medical Systems USA, Inc.
Lead SponsorINDUSTRY

Study design

Observational model
CASE_CROSSOVER
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Female subjects participating in FMSU2013-004A protocol with known clinical status

Exclusion criteria

* Female subjects that did not have known clinical status in FMSU2013-004A

Design outcomes

Primary

MeasureTime frameDescription
Comparison of ISR (Modified Processing) to FBP (Original Processing)1 day reading sessionFor each reader, the cases judged as non-inferior with modified processing will be calculated for each feature and each view. Non-inferiority will be defined as a score of equivalence between modified and original or a score indicating the modified image processing is superior. Readers compared several general mammographic features using the following 5-point scale: negative 2 (left image much superior) negative 1 (left image somewhat superior) 0 (left and right images are equivalent) positive 1 (right image somewhat superior) positive 2 (right image much superior)

Countries

United States

Participant flow

Pre-assignment details

6 qualified radiologists were shown DBT (Tomosynthesis) of a breast with the modified processing side-by-side the same breast with the original processing. Each reader was given a unique sample of 100 cases to review. Images were acquired under Fujifilm image acquisition protocol FMSU2013-004A

Participants by arm

ArmCount
FBP (Old Processing)/ISR (New Processing)
Filtered back projection (old processing) and ISR (new processing) images of the same breast are presented side-by-side for radiologist review.
600
Total600

Baseline characteristics

CharacteristicFBP (Old Processing)/ISR (New Processing)
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
37 Participants
Age, Categorical
Between 18 and 65 years
563 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
7 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
590 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
3 Participants
Region of Enrollment
United States
600 participants
Sex: Female, Male
Female
600 Participants
Sex: Female, Male
Male
0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 6000 / 600
other
Total, other adverse events
0 / 6000 / 600
serious
Total, serious adverse events
0 / 6000 / 600

Outcome results

Primary

Comparison of ISR (Modified Processing) to FBP (Original Processing)

For each reader, the cases judged as non-inferior with modified processing will be calculated for each feature and each view. Non-inferiority will be defined as a score of equivalence between modified and original or a score indicating the modified image processing is superior. Readers compared several general mammographic features using the following 5-point scale: negative 2 (left image much superior) negative 1 (left image somewhat superior) 0 (left and right images are equivalent) positive 1 (right image somewhat superior) positive 2 (right image much superior)

Time frame: 1 day reading session

Population: Six readers read a cohort of images acquired under a prior acquisition study protocol (FMSU2013-004A). Statistician provided results for ISR (modified/new processing only) that was already analyzed/compared to FBP (old processing).

ArmMeasureGroupValue (MEAN)
ISR (New Processing)Comparison of ISR (Modified Processing) to FBP (Original Processing)MLO0.83 5-point scale
ISR (New Processing)Comparison of ISR (Modified Processing) to FBP (Original Processing)Uniformity0.83 5-point scale
ISR (New Processing)Comparison of ISR (Modified Processing) to FBP (Original Processing)Contrast0.80 5-point scale
ISR (New Processing)Comparison of ISR (Modified Processing) to FBP (Original Processing)Sharp0.79 5-point scale
ISR (New Processing)Comparison of ISR (Modified Processing) to FBP (Original Processing)Skin0.84 5-point scale
ISR (New Processing)Comparison of ISR (Modified Processing) to FBP (Original Processing)Noise0.83 5-point scale
ISR (New Processing)Comparison of ISR (Modified Processing) to FBP (Original Processing)Artifact0.84 5-point scale
ISR (New Processing)Comparison of ISR (Modified Processing) to FBP (Original Processing)Mass0.63 5-point scale
ISR (New Processing)Comparison of ISR (Modified Processing) to FBP (Original Processing)Calcification0.87 5-point scale
ISR (New Processing)Comparison of ISR (Modified Processing) to FBP (Original Processing)Arch Distortion/Asymmetry0.64 5-point scale

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026